Sweet Earth Holdings Corp. (CSE:SE) (FSE:1KZ1) (“Sweet Earth”) is pleased to announce that it has signed a Definitive Supply Agreement (the “Supply Agreement”) with Thoughtful Brands Inc. (“Thoughtful Brands”) to supply dog treats under Thoughtful Brands. On June 22, 2020 Sweet Earth announced a Letter of Intent with Mota Ventures Corp., which has subsequently changed its name to Thoughtful Brands Inc.

Under the Supply Agreement, Sweet Earth is to officially become Thoughtful Brands’ exclusive dog treat provider, which will be marketed and sold on under the brand name Nature’s Exclusive, a key line in Thoughtful Brand’s rapidly expanding global natural health products and ecommerce technology platform.

Keep reading... Show less

Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce that it has closed its non-brokered private placement financing for a total of 15,887,503 units (the “Units”) at $0.06 per Unit, for total gross proceeds of $1,053,250 (the “Offering”). Due to oversubscribed demand, the private placement financing was increased from 14,166,667 Units to 17,554,167.

Each Unit consists of one common share of Naturally Splendid and one half of a common share purchase warrant (each a “Warrant”), with each Warrant entitling the holder to purchase one additional common share for a period of two years from the date of the issue at an exercise price of $0.10 per share. Naturally Splendid has the right to accelerate the expiry date of the Warrants if, at any time, the average closing price of Naturally Splendid’s common shares is equal to or greater than $0.15 for 10 consecutive trading days. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after Naturally Splendid issues a news release announcing that it has elected to exercise this acceleration right.

Keep reading... Show less

GreenStar Biosciences (CSE:GSTR, OTC Pink:GTSIF) has launched their campaign on the Investing News Network’s life science channel.

GreenStar Biosciences (CSE:GSTR, OTC Pink:GTSIF) is a company focused on growth-oriented technologies with its core interest in transformational medicines and wellness. In particular, the company is targeting the psychedelic market in large part thanks to acquisitions and development of assets, products and technologies.

Keep reading... Show less

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces that World High Life Plc, (AQSE LIFE) (OTCQB:WRHLF), in which the Company has invested, has announced that brand ambassador Georges St-Pierre will be showcased on BT Sport, one of Europe’s largest sport networks and rights holder for UFC (Ultimate Fighting Championships) in the U.K.

Georges “Rush” St-Pierre, also known as “GSP,” is a Canadian professional mixed martial artist and 3-time UFC world champion who holds black belts in both Kyokushin karate and Brazilian Jiu Jitsu. As Brand Ambassador, Mr. St-Pierre facilitates and provides promotional services, including branding, social media, product placement, endorsement and overall support of the World High Life and the Love Hemp brand.

Keep reading... Show less

Cardiol Therapeutics Inc. (TSX:CRDL) (OTCQX:CRTPF) (“Cardiol” or the “Company”), a leader in the development of pharmaceutical cannabidiol formulations for the treatment of cardiovascular diseases, including heart failure and acute myocarditis, is pleased to announce the initiation of its Health Canada approved Phase 1 clinical study of CardiolRx™. CardiolRx is an extra strength formulation of pharmaceutical cannabidiol that has been formulated to set the highest industry standard for purity, consistency, and stability.

Cardiol’s Phase 1 clinical trial is a double-blind, placebo-controlled, randomized study to assess safety, tolerability, and pharmacokinetics of single followed by multiple day ascending doses of CardiolRx administered orally in up to 55 healthy adult subjects, both in the fasting and fed states. The study is expected to be completed during Q4, 2020, and is believed to represent the first Health Canada approved study of a high concentration (100 mg/mL) cannabidiol formulation that contains virtually no THC (<5 ppm). This level of purity is extremely important for patient populations who should not take THC, particularly children, where THC can impact brain development, and older individuals who wish to avoid intoxication and who may be more susceptible to adverse drug effects.

Keep reading... Show less
  • MustGrow has confirmed disease control of Clubroot resting spores in greenhouse soil tests.
  • Outstanding Efficacy: 96.1% control at 0.5 gal/acre and 98.5% control at 10 gal/acre.
  • Clubroot is a devastating soil-borne disease-causing canola crop loss with no effective treatment options currently available.

MustGrow Biologics Corp. (CSE:MGRO) (OTCQB:MGROF) (FSE:0C0) (the “Company”, “MustGrow”) is pleased to announce successful greenhouse soil test results of its patented mustard-derived bio-pesticide on clubroot resting spores (Plasmodiophora brassicae) (“Clubroot”). With successful greenhouse soil efficacy, MustGrow will advance to larger scale Clubroot field tests in 2021. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

Highlights:

Keep reading... Show less